Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117385) titled 'Study on the Effectiveness and Safety of Irreversible Electroporation for Treating Hepatocellular Liver Cancer' on Jan. 23.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital, Sichuan University
Condition:
Hepatocellular Carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-23
Target Sample Size: Experimental group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=283943
Disclaimer: Curated by HT Syndication....